An off-stage interview with Andrew Lacy, CEO of Prenuvo.

On the FH25 stage, he explored how early detection technologies are reshaping the foundation of medicine. By combining advanced whole-body MRI imaging, blood biomarkers, and AI, he outlined a model of care that identifies disease before symptoms and empowers individuals to take action earlier. His keynote highlighted how proactive health can extend longevity, reduce costs, and align innovation with sustainability and access.